Table 2.
|
INPATIENT: ADULT |
INPATIENT: ADOLESCENT |
DAYPATIENT: ADULT |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean (SD) Admission N =150 | Mean (SD) Discharge (N = 137) | Test statistics | ES | Mean (SD) Admission N = 11 | Mean (SD) Discharge (N = 7) | Test statistics | ES | Mean (SD) Admission (N = 16) | Mean (SD) Discharge (N = 15) | Test statistics | ES | |
AGE |
26.5 (8.9) |
|
|
|
15.2 (1.6) |
|
|
|
24.7 (5.3) |
|
|
|
AGE ONSET |
16.8 (5.6) |
|
|
|
13.5 (1.4) |
|
|
|
16.1 (4.1) |
|
|
|
LENGTH ILL (YEARS) |
8.2 (8.3) |
|
|
|
2.0 (1.7) |
|
|
|
7.3 (7.0) |
|
|
|
LOWEST BMI |
12.6 (1.7) |
|
|
|
14.0 (2.0) |
|
|
|
14.6 (1.6) |
|
|
|
# PREVIOUS ADMISSIONS a |
1.0 (0-2.0) |
|
|
|
0.4 (0.5) |
|
|
|
0 (0-2.0) |
|
|
|
Treatment |
|
|
|
|
|
|
|
|
|
|
|
|
LoS (weeks) |
|
26.4 (17.9) |
|
|
|
29.0 (11.9) |
|
|
|
17.8 (10.4) |
|
|
Weight gain |
|
|
|
|
|
|
|
|
|
|
|
|
BMI |
14.0 (1.7) |
17.3 (2.1) |
-21.4,
p
< .001 |
1.7 |
15.0 (1.6) |
18.5 (1.3) |
-5.6,
p
= .001 |
3.1 |
17.3 (2.4) |
18.5 (2.2) |
-2.1, p = .059 |
0.4 |
Weight (kgs) |
38.3 (6.0) |
47.1 (7.5) |
-20.6,
p
< .001 |
1.3 |
40.8 (6.1) |
50.9 (5.3) |
-5.6,
p
= .003 |
2.1 |
45.1 (7.4) |
48.4 (6.0) |
-2.0, p = .065 |
0.4 |
Weekly gain (kg) |
|
0.4 (0.3) |
|
|
|
0.5 (0.4) |
|
|
|
0.1 (0.3) |
|
|
BMI 6 weeks* |
|
15.1 (1.8) |
|
|
|
15.1 (1.1) |
|
|
|
17.5 (2.4) |
|
|
6wk rate of weekly weight * |
|
0.6 (0.5) |
|
|
|
0.2 (0.2) |
|
|
|
-0.2 (0.4) |
|
|
Eating psychopathology (0-6) and behaviours | ||||||||||||
EDE-Q Total |
4.2 (1.3) |
3.3 (1.6) |
6.5,
p
< .001 |
-0.6 |
4.1 (1.4) |
3.5 (1.0) |
0.3, p = .778 |
-0.2 |
4.4 (1.0) |
3.7 (1.3) |
2.7,
p
= .020 |
-0.7 |
EDE-Q Restraint |
3.7 (1.8) |
2.9 (1.9) |
3.7,
p
< .001 |
-0.4 |
3.7 (2.2) |
2.7 (1.2) |
0.3, p = .802 |
-0.2 |
3.6 (2.0) |
3.3 (1.4) |
1.4, p = .186 |
-0.2 |
EDE-Q Eating Concern |
3.7 (1.3) |
2.8 (1.5) |
6.3,
p
< .001 |
-0.6 |
3.6 (1.5) |
3.0 (1.5) |
-0.1, p = .898 |
-0.1 |
4.0 (1.1) |
3.3 (1.4) |
2.3,
p
= .041 |
-0.7 |
EDE-Q Shape Concern |
5.0 (1.2) |
4.1 (1.8) |
5.9,
p
< .001 |
-0.5 |
5.2 (0.8) |
4.8 (0.8) |
0.8, p = .499 |
-0.3 |
5.3 (0.9) |
4.5 (1.5) |
2.8,
p
= .016 |
-0.8 |
EDE-Q Weight Concern |
4.5 (1.4) |
3.3 (1.7) |
7.2,
p
< .001 |
-0.7 |
4.1 (1.7) |
3.7 (1.1) |
0.4, p = .729 |
-0.3 |
4.7 (1.1) |
3.7 (1.4) |
2.9,
p
= .012 |
-0.8 |
OBE: Yes |
55 (37%) |
37 (31%) |
p = .440 |
-0.2 |
3 (38%) |
3 (50%) |
p = 1.0 |
0.3 |
7 (44%) |
10 (67%) |
p = .250 |
0.6 |
LOC: Yes |
82 (59%) |
62 (56%) |
p = .871 |
-0.1 |
3 (43%) |
2 (40%) |
p = 1.0 |
-0.1 |
12 (75%) |
8 (52%) |
p = .625 |
-0.6 |
SIV: Yes |
42 (30%) |
26 (23%) |
p = 1.0 |
-0.2 |
2 (29%) |
1 (20%) |
p = 1.0 |
-0.3 |
6 (38%) |
5 (39%) |
p = 1.0 |
0.0 |
LAX: Yes |
29 (20%) |
12 (11%) |
p = .152 |
-0.4 |
0 |
1 (20%) |
p = 1.0 |
- |
3 (19%) |
2 (15%) |
p = 1.0 |
-0.2 |
DIUR: Yes |
8 (6%) |
0 |
p = .063 |
- |
0 |
0 |
- |
- |
1 (6%) |
2 (15%) |
p = 1.0 |
-0.5 |
EXC. EX: Yes |
83 (58%) |
41 (37%) |
p
= .012 |
-0.5 |
5 (63%) |
1 (20%) |
p = .500 |
-1.2 |
7 (44%) |
7 (54%) |
p = 1.0 |
0.3 |
Mood and Quality of life | ||||||||||||
DASS total |
77.8 (27.9) |
64.8 (31.7) |
4.9,
p
< .001 |
-0.4 |
75.3 (33.4) |
36.0 (16.4) |
1.5, p = .233 |
-0.9 |
79.1 (25.2) |
67.5 (33.0) |
1.1, p = .277 |
-0.4 |
DASS Depression |
28.4 (11.3) |
24.3 (12.7) |
3.8,
p
< .001 |
-0.3 |
30.5 (11.8) |
14.0 (8.9) |
1.2, p = .309 |
-0.9 |
29.5 (10.8) |
25.1 (14.7) |
1.0, p = .316 |
-0.4 |
DASS Anxiety |
20.3 (10.6) |
15.7 (11.7) |
4.5,
p
< .001 |
-0.4 |
15.5 (12.4) |
8.4 (5.2) |
p = .285 |
-0.4 |
20.1 (7.6) |
18.9 (10.1) |
-0.4, p = .726 |
-0.3 |
DASS Stress |
29.1 (9.7) |
24.7 (10.7) |
4.3,
p
< .001 |
-0.4 |
29.3 (10.9) |
13.6 (6.5) |
1.9, p = .155 |
-1.3 |
29.5 (8.6) |
23.5 (9.7) |
1.7, p = .108 |
-0.7 |
WHO QoL (1-5) |
2.4 (1.0) |
3.2 (0.9) |
-6.7,
p
< .001 |
0.8 |
2.3 (0.9) |
4.0 (1.0) |
-2.0, p = .141 |
1.6 |
2.9 (1.0) |
2.8 (1.3) |
0.4, p = .721 |
-0.1 |
WHO HEALTH (1-5) |
2.3 (0.9) |
2.9 (1.0) |
-5.0,
p
< .001 |
0.5 |
3.0 (1.2) |
4.2 (0.8) |
-1.2, p = .308 |
0.6 |
2.4 (1.0) |
2.3 (1.0) |
0.4, p = .721 |
-0.1 |
WHO Psychological |
26.2 (17.5) |
35.5 (19.5) |
-5.6,
p
< .001 |
0.5 |
26.0 (18.2) |
46.7 (20.5) |
-0.7, p = .519 |
0.5 |
22.1 (17.3) |
26.3 (20.7) |
-0.9, p = .378 |
0.2 |
WHO Social |
40.2 (22.1) |
40.8 (21.7) |
0.6, p = .581 |
0.1 |
38.0 (31.6) |
41.7 (25.7) |
0.7, p = .537 |
0.3 |
33.3 (18.0) |
26.3 (17.3) |
0.3, p = .764 |
-0.1 |
WHO Physical |
51.0 (20.0) |
62.2 (20.8) |
-5.3,
p
< .001 |
0.5 |
67.0 (20.4) |
86.4 (8.5) |
-1.6, p = .207 |
0.3 |
46.2 (18.1) |
45.3 (22.6) |
0.7, p = .484 |
-0.1 |
WHO Environment |
52.7 (16.9) |
61.2 (17.0) |
-5.2,
p
< .001 |
0.4 |
56.6 (14.0) |
72.5 (19.8) |
-1.6, p = .215 |
0.7 |
53.6 (9.9)-0.2 |
50.3 (16.1) |
1.1, p = .296 |
|
Motivation (1-10) | ||||||||||||
Importance to change |
8.0 (2.3) |
7.5 (2.5) |
2.6,
p
= .010 |
-0.3 |
6.3 (4.3) |
4.2 (3.3) |
2.1, p = .127 |
-0.6 |
8.9 (1.1) |
8.4 (2.5) |
0.5, p = .603 |
-0.2 |
Confidence to change |
5.5 (2.6) |
5.4 (2.5) |
1.2, p = .222 |
-0.1 |
5.0 (2.5) |
6.2 (2.3) |
-0.9, p = .448 |
0.6 |
5.0 (2.0) |
4.7 (2.6) |
0.4, p = .711 |
-0.3 |
Perceived support from carers | ||||||||||||
LEE primary carer |
20.0 (15.4) |
18.3 (13.8) |
1.3, p = .182 |
-0.1 |
20.6 (15.0) |
14.7 (6.7) |
0.2, p = .858 |
-0.1 |
19.0 (9.9) |
22.5 (12.9) |
-1.2, p = .249 |
0.3 |
PCS Mother |
2.4 (1.0) |
2.4 (1.0) |
-0.5, p = .633 |
0.0 |
2.0 (0.8) |
1.8 (0.1) |
0.5, p = .670 |
-0.04 |
2.5 (0.9) |
2.5 (0.9) |
-0.1, p = .902 |
-0.02 |
PCS Father | 2.2 (1.0) | 2.1 (0.9) | 0.5, p = .618 | -0.04 | 1.9 (0.5) | 1.9 (0.3) | -0.04, p = .973 | 0.03 | 2.4 (1.0) | 2.5 (1.3) | -0.4, p = .708 | -0.1 |
* Not every participant answered every question; a Median and IQR reported. b data for one site not presented in isolation as only 2 participants were inpatients; day patients are not included in individual site calculations; ES: Effect size; SD: Standard Deviation; N = sample number included; BMI: Body Mass Index; EDE-Q Eating Disorder Examination Questionnaire; OBE: Objective binge episodes with loss of control; LOC: Loss of control other than binge; SIV: Self-induced vomiting; LAX: Laxative use; EXER: Excessive exercise; DASS: Depression, Anxiety and Stress Scale; WHO: World Health Organization; QoL: Overall quality of life (1–5 high); HEALTH: Overall satisfaction with health (1–5 high); LEE: Levels of Expressed Emotion; PCS: Psychological Control Scale; Analyses for change over treatment period for adolescent and day patient samples were conducted using t-tests (data presented in table) and Wilcoxin Signed Ranks test for non-parametric data because of small sample sizes. There were no differences in the pattern of results. Bold values indicate a statistically significant result.